Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision medicine for gestational diabetes treated with metformin
NL-OMON51350Terminated
- Sponsor
- Zuyderland
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Zuyderland. Primary endpoints: Time in range during 7-day continuous glucose monitoring and Requirement for additional insulin treatment. Started Oct 2023; status: terminated.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NL-OMON51350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51350.